A vascular access sheath includes an inner support structure extends from a hemostasis valve toward a distal end section of the access sheath. An outer polymer is disposed over the inner support structure, where the outer polymer has an exterior surface extending from the hemostasis valve to a distal tip of the access sheath. The outer polymer has a consistent thickness along the access sheath and defines a greater durometer an intermediate section of the access sheath than at the proximal and distal end sections of the access sheath. The outer polymer also has a secondary lumen disposed between the exterior surface and the central lumen, where the secondary lumen extends at least partially along the length of the access sheath and is configured to receive a wire to reinforce the stiffness of the intermediate section of the access sheath.

Devices and methods of treating fluid retention caused by congestive heart failure or other conditions resulting in edema, lymphoedema, or significant fluid retention (e.g., deep vein thrombosis, cellulitis, venous stasis insufficiency, or damage to the lymphatic network) are described. Specifically, a treatment device is used to create a passage or cannula between the lymphatic system (or other area of the body) and an external drainage device. This device can be only temporarily located in the patient or can be implanted within the patient for longer periods of time. The physician can safely and reliably remove excess fluid from the body via the device and optionally inject other treatment agents.

The present invention relates to a an anti-thrombotic medical instrument and catheter medical instrument comprising: base with a port for connection to an infusion set; a catheter extending from the base, and comprises a main body of tubular configuration. a plurality of lateral conduits distributed along the length of the catheter; an elastomeric cover over each lateral conduit, said elastomeric cover opens with a fluid flow inside the catheter and closes when the fluid flow stops. Said lateral conduits have an angle in the range of 15° to 60° to the longitudinal axis of the catheter.

A device for the uninterrupted administration of fluid to an animal body during a draw of bodily fluid, e.g., blood, is disclosed. A first fluid channel is configured to selectively transport IV fluid to an animal body and to draw a bodily fluid from the body. A sealing member for sealing a bodily fluid draw port defines a concave surface on a first end. The sealing member concave surface forms an interior surface portion of the first fluid channel. A connection member is configured to connect to a catheter to the first fluid channel and defines a concave distal end. A second fluid channel continuously provides IV fluid to a lumen coaxially located within the catheter. The concave surface and the concave distal end are shaped to create fluid flow patterns that quickly and completely remove residual bodily fluid remaining after a draw of bodily fluid is completed.

A hemostasis valve hub for a sheath, such as an introducer sheath, includes a hub base including a first arm defining a first lumen and having a distal end and a proximal end and a second arm extending from the first arm and defining a second lumen and having a distal end and a proximal end, a seal positioned within the first lumen and adjacent a lock nut, the lock nut engaged with the proximal end of the first arm and positioned at least partially within the first lumen, a primary seal positioned adjacent the proximal end of the first arm, and a secondary seal positioned adjacent the proximal end of the second arm.

An instrument configured to be inserted through a vascular access device includes a helical coil formed by a wire, with the helical coil defining a central passage, and a core wire extending along a longitudinal axis of the helical coil through at least a portion of the central passage of the helical coil. At least a portion of the core wire includes a planar surface extending in a direction along the longitudinal axis and a semi-cylindrical surface extending in a direction along the longitudinal axis.

A device for intravascular intervention can comprise an interventional element, an elongate manipulation member having a retention portion, and a joining element. The elongate element can comprise a distally located attachment portion. The interventional element includes a proximal end portion with a hole therethrough, the attachment portion of the elongate member extending through the hole at the bend such that first and second segments of the elongate member each extend proximally from the hole. A retention portion includes an arm extends proximally of the hole and a shoulder protruding radially outwardly from a proximal portion of the arm. A joining element circumferentially surrounds at least a portion of the retention portion and at least a portion of the first and second segments of the elongate member such that a proximal end of the joining element is positioned distal to the shoulder of the retention portion.

An access closure device for closing an opening in tissue is provided. The access closure device may comprise a balloon delivery system and a sealant delivery system. The balloon delivery system may comprise a suture, a delivery shaft, an inflatable balloon, and a balloon segment releasably attached to the delivery shaft. The sealant delivery system may comprise a sealant delivery shaft, an ejection tube, and a snare wire configured to snare a suture of the delivery system.

A sheath for producing a fully sealed access to the interior of a vessel of an animal or human body comprises a base sheath having a tubular body defining a pass-through channel. The base sheath is adapted to be inserted into the vessel through a vessel aperture. The sheath further comprises an expansion device which is adapted to cooperate with the base sheath such that the outer diameter of the sheath increases in the region of the vessel aperture with the sheath in a stationary position in the vessel and upon actuation of the expansion device.

An arteriovenous graft system is described. The arteriovenous graft system includes an arteriovenous graft that is suited for use during hemodialysis. In order to minimize or prevent arterial steal, at least one valve device is positioned at the arterial end of the arteriovenous graft. In one embodiment, for instance, the arteriovenous graft systems includes a first valve device positioned at the arterial end and a second valve device positioned at the venous end. In one embodiment, the valve devices may include an inflatable balloon that, when inflated, constricts and closes off the arteriovenous graft. If desired, a single actuator can be used to open and close both valve devices.